Etersalate is used for its antiplatelet properties, inhibiting platelet function and reducing thromboxane A2 (TXA2) levels; it also modulates arachidonic acid metabolism in platelets at a site distinct from the cyclooxygenase pathway, while stimulating prostaglandin I2 (PGI2) generation.